HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Pathmanathan, A. Articles by Waterer, G. W. Search for Related Content PubMed PubMed Citation Articles by Pathmanathan, A. Articles by Waterer, G. W.

Significance of positive Stenotrophomonas maltophilia culture in acute respiratory tract infection

Dept of Respiratory Medicine, Royal Perth Hospital, Perth, Australia

CORRESPONDENCE: G. W. Waterer, School of Medicine and Pharmacology, University of Western Australia, Dept of Respiratory Medicine, Royal Perth Hospital, GPO Box X2213, Perth 6847, Western Australia, Australia. Fax: 61 892240246. E-mail: waterer@cyllene.uwa.edu.au

Keywords: Outcome, respiratory, Stenotrophomonas maltophilia, treatment

Received: August 18, 2004
Accepted December 30, 2004

Stenotrophomonas maltophilia is a common coloniser of the respiratory tract of patients with chronic lung disease, and, in the absence of pneumonia or bacteraemia, is often ignored by physicians at the Royal Perth Hospital (Perth, Australia). Experience at the Royal Perth Hospital was reviewed to determine whether ignoring S. maltophilia in this setting has any apparent effect on clinical outcome.

All patients who presented with an acute respiratory illness and yielded a positive culture for S. maltophilia between 1995 and 2002 were retrospectively reviewed. All subjects had to yield a positive respiratory isolate of S. maltophilia and undergo chest radiography within 24 h of the isolate being obtained.

Ninety-two episodes were identified in 89 individuals; 64 showed no evidence of consolidation. Of the study group, 51 (80.0%) received no anti-S. maltophilia antibiotic therapy and 21 (32.8%) had a nosocomially acquired isolate. The overall mortality rate was 20.3%. There was no impact of anti-S. maltophilia therapy on outcome. The only independent predictor of mortality was serum albumin level.

As there was no measurable impact of antibiotic therapy, in the absence of consolidation, a positive respiratory tract isolate of Stenotrophomonas maltophilia probably represents colonisation of a severely impaired host rather than invasive disease.

This article has been cited by other articles:

				M. E. Falagas, P.-E. Valkimadi, Y.-T. Huang, D. K. Matthaiou, and P.-R. Hsueh Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review J. Antimicrob. Chemother., November 1, 2008; 62(5): 889 - 894. [Abstract] [Full Text] [PDF]

				V. J. Waters, M. I. Gomez, G. Soong, S. Amin, R. K. Ernst, and A. Prince Immunostimulatory Properties of the Emerging Pathogen Stenotrophomonas maltophilia Infect. Immun., April 1, 2007; 75(4): 1698 - 1703. [Abstract] [Full Text] [PDF]